
Company Info
Phone(253) 922-2600
Year Established
2000
Contacts
Greg ArchambeauPresident
Bert van den Bergh
Executive Chair
Andreas Kalmes, PhD
VP, Drug Development
Neil Price
VP, Finance
Company Description
Revalesio is a clinical-stage pharmaceutical company with a vision to change the future of treatment for people with neurological diseases through the development of effective and well tolerated medicines.